Bora Pharmaceuticals Q4 2025 Financial Report
Bora Pharmaceuticals reported a basic EPS of NT3.90, revenue of NT9.014 billion, and net income after tax of NT.046 billion for Q4 2025.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
Company Code: 6472 Company Name: Bora Pharmaceuticals Co., Ltd. Industry: Biotechnology and Medical Care Industry Period: Q4 2025 Basic Earnings Per Share (EPS): NT3.90 Operating Revenue: NT9.014 billion Net Income After Tax: NT.046 billion